Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 2379-2385, May 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belizario, J. E.
Right arrow Articles by Dinarello, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belizario, J. E.
Right arrow Articles by Dinarello, C. A.

Interleukin 1, Interleukin 6, Tumor Necrosis Factor, and Transforming Growth Factor ß Increase Cell Resistance to Tumor Necrosis Factor Cytotoxicity by Growth Arrest in the G1 Phase of the Cell Cycle1

José E. Belizario and Charles A. Dinarello2

Department of Medicine, Tufts University School of Medicine, and New England Medical Center, Boston, Massachusetts 02111

During infection, inflammation, immune responses, and neoplastic growth, various cytokines are produced affecting both susceptibility to and protection from cellular death. We have studied the protective effect of pretreatment of the L929 fibroblast cell line with interleukin 1ß (IL-1ß), IL-6, tumor necrosis factor {alpha} (TNF-{alpha}), or transforming growth factor ß1 (TGF-ß) on subsequent TNF/actinomycin D-induced cytotoxicity. The protective effects of these cytokines on TNF cytotoxicity were time and concentration dependent. TGF-ß was the most effective cytokine, followed by TNF, IL-1ß, and IL-6. Activators of protein kinase C also afforded protection, and TGF-ß acted synergistically with either phorbol 12-myristate 13-acetate or the calcium ionophore A-23187. TGF-ß-induced protection against TNF was observed in cells subjected to prolonged treatment with phorbol 12-myristate 13-acetate. Cells pretreated with prostaglandin E2 or cholera toxin amplified the sensitivity to TNF and inhibited TGF-ß-mediated resistance, whereas indomethacin enhanced the protective effect of TGF-ß. Cells cultured in the presence of IL-1ß, IL-6, TNF-{alpha}, or TGF-ß for 6 h inhibited DNA synthesis, and this was associated with concomitant growth arrest in the G1 phase of the cell cycle. On the other hand, prostaglandin E2 or cholera toxin stimulated the progression of cells from G1 toward G2 + M which was associated with increased TNF sensitivity. We conclude that these cytokines protect against death by arresting growth in the G1 phase of the cell cycle.

1 This study is supported by NIH Grant AI-15614. J. E. B. is supported by a Fellowship of the Ministry of Science and Technology of Brazil (CNPq).

2 To whom requests for reprints should be addressed, at the Department of Medicine, New England Medical Center, 750 Washington St. Boston, MA 02111.

Received 8/30/90. Accepted 2/22/91.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. S. Muraoka-Cook, H. Kurokawa, Y. Koh, J. T. Forbes, L. R. Roebuck, M. H. Barcellos-Hoff, S. E. Moody, L. A. Chodosh, and C. L. Arteaga
Conditional Overexpression of Active Transforming Growth Factor {beta}1 In vivo Accelerates Metastases of Transgenic Mammary Tumors
Cancer Res., December 15, 2004; 64(24): 9002 - 9011.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. G. Agrawal, J. Marquet, J. Plumas, H. Rouard, M.-H. Delfau-Larue, P. Gaulard, L. Boumsell, F. Reyes, A. Bensussan, and J.-P. Farcet
Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue
Int. Immunol., April 1, 2001; 13(4): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
S. W. Tobin, M. K. Brown, K. Douville, D. C. Payne, A. Eastman, and B. A. Arrick
Inhibition of Transforming Growth Factor {beta} Signaling in MCF-7 Cells Results in Resistance to Tumor Necrosis Factor {{alpha}}: A Role for Bcl-2
Cell Growth Differ., February 1, 2001; 12(2): 109 - 117.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
W. H. Wilson, L. Sorbara, W. D. Figg, E. K. Mont, E. Sausville, K. E. Warren, F. M. Balis, K. Bauer, M. Raffeld, A. M. Senderowicz, et al.
Modulation of Clinical Drug Resistance in a B Cell Lymphoma Patient by the Protein Kinase Inhibitor 7-Hydroxystaurosporine: Presentation of a Novel Therapeutic Paradigm
Clin. Cancer Res., February 1, 2000; 6(2): 415 - 421.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
R. L. Chelvarajan, N. L. Gilbert, and S. Bondada
Neonatal Murine B Lymphocytes Respond to Polysaccharide Antigens in the Presence of IL-1 and IL-6
J. Immunol., October 1, 1998; 161(7): 3315 - 3324.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F.-h. Xu, S. Sharma, A. Gardner, Y. Tu, A. Raitano, C. Sawyers, and A. Lichtenstein
Interleukin-6-Induced Inhibition of Multiple Myeloma Cell Apoptosis: Support for the Hypothesis That Protection Is Mediated Via Inhibition of the JNK/SAPK Pathway
Blood, July 1, 1998; 92(1): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. J. Donato and M. Perez
Tumor Necrosis Factor-induced Apoptosis Stimulates p53 Accumulation and p21WAF1 Proteolysis in ME-180 Cells
J. Biol. Chem., February 27, 1998; 273(9): 5067 - 5072.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Bellido, V. Z. C. Borba, P. Roberson, and S. C. Manolagas
Activation of the Janus Kinase/STAT (Signal Transducer and Activator of Transcription) Signal Transduction Pathway by Interleukin-6-Type Cytokines Promotes Osteoblast Differentiation
Endocrinology, September 1, 1997; 138(9): 3666 - 3676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Furukawa, S. Iwase, Y. Terui, J. Kikuchi, T. Sakai, M. Nakamura, S. Kitagawa, and M. Kitagawa
Transcriptional Activation of the cdc2 Gene Is Associated with Fas-induced Apoptosis of Human Hematopoietic Cells
J. Biol. Chem., November 8, 1996; 271(45): 28469 - 28477.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Borner and C. Borner
Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2
J. Biol. Chem., May 31, 1996; 271(22): 12695 - 12698.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Meikrantz and R. Schlegel
Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein Kinases
J. Biol. Chem., April 26, 1996; 271(17): 10205 - 10209.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Muthukkumar, S. F. Sells, S. A. Crist, and V. M. Rangnekar
Interleukin-1 Induces Growth Arrest by Hypophosphorylation of the Retinoblastoma Susceptibility Gene Product RB
J. Biol. Chem., March 8, 1996; 271(10): 5733 - 5740.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N.-S. Chang and N. S. Chang
Transforming Growth Factor-beta1 Induction of Novel Extracellular Matrix Proteins That Trigger Resistance to Tumor Necrosis Factor Cytotoxicity in Murine L929 Fibroblasts
J. Biol. Chem., March 31, 1995; 270(13): 7765 - 7772.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.